ArticleGenes & diseases2023

Phase I trial of human umbilical cord-derived mesenchymal stem cells for treatment of severe bronchopulmonary dysplasia.

Yunqiu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.